Abstract
Anticancer drugs are a group of pharmaceuticals that are used in cancer treatment. These drugs have high pharmacological potency and are designed to kill tumour cells or to prevent and disrupt tumour cell division by interfering with genetic material or processes that govern their replication. However, anticancer drugs do not affect only cancer cells but also dividing normal cells. After human consumption, anticancer drug residues are released into the environment as parent compounds and their metabolites, where they might affect non-target environmental organisms even at the level of sub- to few ng/L in particular during chronic exposure. Recent ecotoxicological studies that included also detection of genotoxic effects of selected anticancer drugs with different mechanisms of chemotherapeutic action demonstrated high differences in the sensitivity of different aquatic organisms in regard to lethal and reproductive effects. However, in all organisms, the concentrations at which mortality and reproductive effects were observed were higher than the concentrations that were detected or expected in the environmental samples. On the contrary, the genotoxic effects of certain anticancer drugs were in crustacean and fish detected at concentrations that may occur in the aquatic environment. Thus, potential ecological risks for invertebrates and vertebrates cannot be ruled out. The results clearly demonstrated that residues of certain anticancer drugs are hazardous for aquatic environment; thus, further research and activities are needed that will enable reliable environmental risk assessment and introduction of measures to reduce their release into the environment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aherne GW, Hardcastle A, Nield AH (1990) Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples. J Pharm Pharmacol 42:741–742
Arora A, Scholar EM (2005) Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther 315:971–979
Besse JP, Latour JF, Garric J (2012) Anticancer drugs in surface waters. What can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs? Environ Int 39:73–86
Bolognesi C, Cirillo S (2014) Genotoxicity biomarkers in aquatic bioindicators. Curr Zool 60:273–284
Bolognesi C, Hayashi M (2011) Micronucleus assay in aquatic animals. Mutagenesis 26:205–213
Booker V, Halsall C, Llewellyn N, Johnson A, Williams R (2014) Prioritising anticancer drugs for environmental monitoring and risk assessment purposes. Sci Total Environ 473-474:159–170
Boxall AB, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S et al (2012) Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 120:1221–1229
Brezovšek P, Elersek T, Filipic M (2014) Toxicities of four anti-neoplastic drugs and their binary mixtures tested on the green alga Pseudokirchneriella subcapitata and the cyanobacterium Synechococcus leopoliensis. Water Res 52:168–177
Buerge IJ, Buser HR, Poiger T, Muller MD (2006) Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ Sci Technol 40:7242–7250
Catastini C, Mullot J-U, Boukari S, Mazellier P, Levi Y, Cervantes P, Ormsby J-N (2008) Assessment of antineoplastic drugs in effluents of two hospitals |Identification de molecules anticancéreuses dans les effluents hospitaliers. J Eur Hydrol 39(2):171–180
Daughton CG (2002) Environmental stewardship and drugs as pollutants. Lancet 360:1035–1036
Dong Z, Senn DB, Moran RE, Shine JP (2013) Prioritizing environmental risk of prescription pharmaceuticals. Regul Toxicol Pharmacol 65:60–67
EMA (European Medicines Agency) (2006) Guidelines on the environmental risk assessment of medicinal products for human use. European Chemical Agency. Doc ref. EMEA/CHMP/SWP/4447/00
European Commission (2003) Technical guidance document on risk assessment in support of commission Directive 93/67/EEC on Risk assessment for new notified substances commission regulation (EC) No 1488/94, on Risk assessment for existing substances directive 98/8/EC of the European parliament and of the council concerning the placing of biocidal products on the market. Institute for Health and Consumer Protection, European Chemicals Bureau
Fent K, Weston AA, Caminada D (2006) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122–159
Ferrando-Climent L, Rodriguez-Mozaz S, Barcelo D (2014) Incidence of anticancer drugs in an aquatic urban system: from hospital effluents through urban wastewater to natural environment. Environ Pollut 193:216–223
Fleming RA (1997) An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy 17:146S–154S
Franquet-Griell H, Cornadó D, Caixach J, Ventura F, Lacorte S (2017) Determination of cytostatic drugs in Besòs River (NE Spain) and comparison with predicted environmental concentrations. Environ Sci Pollut Res 24:6492
Frenzilli G, Nigro M, Lyons BP (2009) The comet assay for the evaluation of genotoxic impact in aquatic environments. Mutat Res Rev Mutat Res 681:80–92
Fuerhacker M et al (2006) Chemische Analyse, Risikobewertungund Entfernung von ausgewählten Zytostatika aus Abwasserströmen aus Krankenhäusern Risikoabschätzung und Risikomanagement, Teil II “Risikoabschätzung und Risikomanagement”. Fördervertrag der ÖKK:GZ A201860, Lebensministerium: 1–168, Wien
Hagner N, Joerger M (2010) Cancer chemotherapy: targeting folic acid synthesis. Cancer Manag Res 2:293–301
Hernando MD, Mezcua M, Fernndez-Alba AR, Barcelo D (2006) Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69:334–342
Hughes SR, Kay P, Brown LE (2013) Global synthesis and critical evaluation of pharmaceutical datasets collected from river systems. Environ Sci Technol 47:661–677
Isidori M, Lavorgna M, Russo C, Kundi M, Zegura B, Novak M, Filipic M, Misik M, Knasmueller S, de Alda ML et al (2016) Chemical and toxicological characterisation of anticancer drugs in hospital and municipal wastewaters from Slovenia and Spain. Environ Pollut 219:275–287
ISO 20665 (2008) Water quality-determination of chronic toxicity to Ceriodaphnia dubia in 7 days-population growth inhibition test. International Organization for Standardization, Geneva
Jackson MA, Stack HF, Waters MD (1996) Genetic activity profiles of anticancer drugs. Mutat Res 355:171–208
Jenkins GJS, Zair Z, Johnson GE, Doak SH (2010) Genotoxic thresholds, DNA repair, and susceptibility in human populations. Toxicology 278:305–310
Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573–584
Kosjek T, Heath E (2011) Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. TrAC Trends Anal Chem 30:1065–1087
Kovacs R, Csenki Z, Bakos K, Urbanyi B, Horvath Ă, Garaj-Vrhovac V, Gajski G, Geric M, Negreira N, Lopez de Alda M et al (2015) Assessment of toxicity and genotoxicity of low doses of 5-fluorouracil in zebrafish (Danio rerio) two-generation study. Water Res 77:201–212
Kovacs R, Bakos K, Urbanyi B, Kovesi J, Gazsi G, Csepeli A et al (2016) Acute and sub-chronic toxicity of four cytostatic drugs in zebrafish. Environ Sci Pollut Res 23:14715–14729
Kummerer K (2009) The presence of pharmaceuticals in the environment due to human use-present knowledge and future challenges. J Environ Manag 90:2354–2366
Kummerer K, Haiss A, Schuster A, Hein A, Ebert I (2014) Antineoplastic compounds in the environment-substances of special concern. Environ Sci Pollut Res Int 23:14791–14804
Kuster A, Adler N (2014) Pharmaceuticals in the environment: scientific evidence of risks and its regulation. Philos Trans R Soc Lond Ser B Biol Sci 369:20130571
Lin AY, Lin YC, Lee WN (2014) Prevalence and sunlight photolysis of controlled and chemotherapeutic drugs in aqueous environments. Environ Pollut 187:170–181
Longley DB, Harkin DP, Johnston PG (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338
Mahnik SN, Rizovski B, Fuerhacker M, Mader RM (2004) Determination of 5-fluorouracil in hospital effluents. Anal Bioanal Chem 380:31–35
Martin J, Camacho-Munoz D, Santos JL, Aparicio I, Alonso E (2011) Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry. J Sep Sci 34:3166–3177
Negreira N, Lopez de Alda M, Barcelo D (2013) On-line solid phase extraction-liquid chromatography-tandem mass spectrometry for the determination of 17 cytostatics and metabolites in waste, surface and ground water samples. J Chromatogr A 1280:64–74
OECD TG 201 (2011) Freshwater alga and cyanobacteria, growth inhibition test. Organization for Economic Cooperation and Development, Paris
OECD TG 202 (2004) Daphnia sp., acute immobilization test. Organization for Economic Co-operation and Development, Paris
OECD TG 203 (1992) Fish, acute toxicity test. Organization for Economic Cooperation and Development, Paris
OECD TG 210 (2013) Fish, early-life stage toxicity test. Organization for Economic Cooperation and Development, Paris
OECD TG 211 (2008) Daphnia magna reproduction test. Organization for Economic Cooperation and Development, Paris
OECD TG 236 (2013) Fish embryo acute toxicity (FET) test. Organization for Economic Cooperation and Development, Paris
Olalla A, Negreira N, Lopez de Alda M, Barcelo D, Valcarcel Y (2018) A case study to identify priority cytostatic contaminants in hospital effluents. Chemosphere 190:417–430
Parrella A, Lavorgna M, Criscuolo E, Russo C, Fiumano V, Isidori M (2014) Acute and chronic toxicity of six anticancer drugs on rotifers and crustaceans. Chemosphere 115:59–66
Parrella A, Lavorgna M, Criscuolo E, Russo C, Isidori M (2015) Eco-genotoxicity of six anticancer drugs using comet assay in daphnids. J Hazard Mater 286:573–580
Pommier Y (2013) Drugging topoisomerases: lessons and challenges. ACS Chem Biol 8:82–95
Rodriguez-Mozaz S, Weinberg HS (2010) Meeting report: pharmaceuticals in water e an interdisciplinary approach to a public health challenge. Environ Health Perspect 118:1016–1020
Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF (2000) Single cell gel/comet assay: guidelines for in-vitro and in-vivo genetic toxicology testing. Environ Mol Mutagen 35:206–221
Toolaram AP, Kummerer K, Schneider M (2014) Environmental risk assessment of anti-cancer drugs and their transformation products: a focus on their genotoxicity characterization-state of knowledge and short comings. Mutat Res Rev Mutat Res 760:18–35
US EPA (1993) Methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms, 4th edn. EPA-600-4-90. US Environmental Protection Agency, Washington, DC
Usawanuwat J, Boontanon N, Boontanon SK (2014) Analysis of three anticancer drugs (5-fluorouracil, cyclophosphamide and hydroxyurea) in water samples by HPLC-MS/MS. Int J Adv Agric Environ Eng 1:2349–1523
Zhang J, Chang VW, Giannis A, Wang JY (2013) Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 445–446:281–298
Zuccato E, Calamari D, Natangelo M, Fanelli R (2000) Presence of therapeutic drugs in the environment. Lancet 355:1789–1790
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Filipič, M., Novak, M., Žegura, B. (2020). Genotoxicity of the Residues of Anticancer Drugs: A Hazard for Aquatic Environment. In: Heath, E., Isidori, M., Kosjek, T., Filipič, M. (eds) Fate and Effects of Anticancer Drugs in the Environment. Springer, Cham. https://doi.org/10.1007/978-3-030-21048-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-21048-9_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21047-2
Online ISBN: 978-3-030-21048-9
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)